BlackRock, Inc. 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BlackRock Inc. BLK |
16,281 2.100% |
-29,111 (-64.13%) |
Filing |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BlackRock Inc. BLK |
45,391 6.500% |
2,827 (+6.64%) |
Filing |